© 博学网 (Boxue58)

 Forgot password?
 注册register
Search
View: 726|Reply: 1
Collapse the left

Drugs of the future 2009 -02 issue

[Copy link]
Post time 2010-2-12 09:00:50 | Show all posts |Read mode

I want to Be A member...

You have to Login for download or view attachment(s). No Account? Register

x
Drugs of the future 2009 -02 issue
Volume 34, Issue 2, February 2009, Pages 97-169  
  
MONOGRAPHS

Darinaparsin.
Organic arsenical, Apoptosis inducer, Oncolytic.
Campas, C., Castaner, R.

Olaparib.
PARP-1 and PARP-2 inhibitor, Oncolytic.
Vasiliou, S., Castaner, R., Bolos, J.

Saracatinib.
Dual Src/ABL kinase inhibitor, Oncolytic.
Dulsat, C., Mealy, N., Castaner, R.

Tosedostat.
Aminopeptidase inhibitor, Oncolytic.
Owen, R.T., Castaner, R., Bolos, J.

REVIEW ARTICLES

Ghrelin receptor agonists for the treatment of gastric emptying disorders.
Meerveld, B.G.-V., Venkova, K.

New approaches to overcoming bacterial resistance.
Fukuda, Y.

The sigma-1 (σ1) receptor and its role in the treatment of mood disorders.
Hayashi, T., Stahl, S.M.

FILLING THE GAPS IN DRUG THERAPY

Gaucher's disease.
Dulsat, C.

TARGETS TO WATCH

Therapeutic targets for bipolar depression.
Sorbera, L.A., Dulsat, C., Rosa, E.
  
MEETING REPORT

The 50th Annual Meeting of the American Society of Hematology: focus on new oncolytic agents in development.
Cole, P., Izco-Basurko, I., Gómez-Zaera, M., Gajdosik, Z.
Guest, if you want to see the hidden content, please Reply
Post time 2016-12-4 06:32:01 | Show all posts
Thanks Hack
You have to log in before you can reply Login | 注册register

Points Rules

Powered by Discuz! X3.2

© 2001-2013 Comsenz Inc.

Quick Reply To Top Return to the list